Tandem Diabetes Care to Announce Fourth Quarter and Full Year 2020 Financial Results on February 24, 2021

Rhea-AI Summary

Tandem Diabetes Care, Inc. (NASDAQ: TNDM) is set to announce its fourth quarter and full year 2020 results on February 24, 2021. The announcement will be followed by a conference call at 4:30 PM ET to discuss financial and operational outcomes. Investors can access the live webcast and find an archived version for 30 days after the event. Tandem is known for its innovative t:slim X2 insulin pump, which features remote software updates and integrated continuous glucose monitoring, emphasizing its commitment to diabetes care improvement.

Positive

• Upcoming Q4 and full year 2020 financial results announcement.
• Innovative product offerings like the t:slim X2 insulin pump.
• User-centric approach to product design and customer experience.

Negative

• None.

Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, plans to release its fourth quarter and full year 2020 results after the financial markets close on Wednesday, February 24, 2021. The Company will hold a conference call and simultaneous webcast on the same day at 4:30 pm Eastern Time (1:30 pm Pacific Time), to discuss its fourth quarter and full year 2020 financial and operating results.

Conference Call/Webcast Details:
Date: February 24, 2021
Time: 4:30 pm Eastern Time (1:30 pm Pacific Time)
Toll Free Dial-In Number: (855) 427-4396
International Dial-In Number: (484) 756-4261
Conference ID: 7178576
Webcast Link: https://edge.media-server.com/mmc/p/272ym8kz

An archive of the webcast will be available for 30 days following the event on Tandem Diabetes Care’s Investor Center website located at http://investor.tandemdiabetes.com in the “Events & Presentations” section.

About Tandem Diabetes Care, Inc.

Tandem Diabetes Care, Inc. (www.tandemdiabetes.com) is a medical device company dedicated to improving the lives of people with diabetes through relentless innovation and revolutionary customer experience. The Company takes an innovative, user-centric approach to the design, development and commercialization of products for people with diabetes who use insulin. Tandem’s flagship product, the t:slim X2™ insulin pump, is capable of remote software updates using a personal computer and features integrated continuous glucose monitoring, and optional automated insulin delivery technology. Tandem is based in San Diego, California.

Follow Tandem Diabetes Care on Twitter @tandemdiabetes, use #tslimX2 and $TNDM.
Follow Tandem Diabetes Care on Facebook at www.facebook.com/TandemDiabetes.
Follow Tandem Diabetes Care on LinkedIn at www.linkedin.com/company/TandemDiabetes.

Tandem Diabetes Care is a registered trademark and t:slim X2 is a trademark of Tandem Diabetes Care, Inc.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210119005833/en/

FAQ

When will Tandem Diabetes Care announce its fourth quarter results?

Tandem Diabetes Care will announce its fourth quarter results on February 24, 2021.

What time will the Tandem conference call take place?

The conference call will take place at 4:30 PM Eastern Time on February 24, 2021.

How can I access the Tandem Diabetes Care Q4 earnings call?

You can access the Tandem Diabetes Care Q4 earnings call via their webcast link provided in the press release.

What is the ticker symbol for Tandem Diabetes Care?

The ticker symbol for Tandem Diabetes Care is TNDM.